Pay in 4 interest-free payments of $5.64 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
GLP-1 Receptor Agonist Market Report Snapshot Market Segmentation By Molecule (Liraglutide, Dulaglutide, Semaglutide, Tirzepatide, and Others): The tirzepatide segment earned USD 27.14 billion in 2025, primarily due to superior efficacy in both glycemic control and weight reduction, rapid uptake among healthcare providers, and expanded diabetes and obesity indications, positioning it as a preferred GLP-1 therapy option
Take home message GLP-1 weight loss injections are evidence-based treatments supported by extensive clinical research, which has shown 15-25% weight loss
doi: 10.21873/invivo.11308 120
Renowned for our premium offerings, we are prominent manufacturers and exporters of collagen peptides, proteins, ox bile extract, food ingredients, yeast extract, cosmetic, bone and joint care ingredients, and more, catering to various essential applications
133 Saedisomeolia, A
Wegovy: In a 68-week trial, adults without diabetes taking Wegovy injections lost an average of 14.9% of their body weight, compared to 2.4% for those on a placebo
)
US$ 24.59
US$ 20.68
US$ 26.06
US$ 28.01
US$ 29.64
US$ 22.47
